Table 1.
DR-associated endothelial ligands identified by comparative ligandomics
CCDS IDProteinBinding activityActivity Ratio
DRControl
DR-high ligands with increased binding to diabetic ECs     
CCDS23347.1     Scg3a      1,731      0        1,732 
CCDS18810     C1qba      837      0        838 
CCDS15031     Fn1a      419      0        420 
CCDS35631     Col4a3a      409      2        137 
CCDS28285     APPa      206      1        104 
CCDS22638     Cdh1a      132      0        133 
DR-low ligands with decreased binding to diabetic ECs     
CCDS40011     HRP-3a      48      11,140        0.0044 
CCDS17457     HDGFa      0      83        0.0119 
Internal positive and negative controls     
VEGF-Phage       408      2,420        0.1689 
GFP-Phage       10      10        1 
Total identified sequences       489,126      473,965  
Total identified ligands       1,548      844  
Diabetes-related ligandsa       353↑      105↓  
CCDS IDProteinBinding activityActivity Ratio
DRControl
DR-high ligands with increased binding to diabetic ECs     
CCDS23347.1     Scg3a      1,731      0        1,732 
CCDS18810     C1qba      837      0        838 
CCDS15031     Fn1a      419      0        420 
CCDS35631     Col4a3a      409      2        137 
CCDS28285     APPa      206      1        104 
CCDS22638     Cdh1a      132      0        133 
DR-low ligands with decreased binding to diabetic ECs     
CCDS40011     HRP-3a      48      11,140        0.0044 
CCDS17457     HDGFa      0      83        0.0119 
Internal positive and negative controls     
VEGF-Phage       408      2,420        0.1689 
GFP-Phage       10      10        1 
Total identified sequences       489,126      473,965  
Total identified ligands       1,548      844  
Diabetes-related ligandsa       353↑      105↓  
a

P < 0.001; DR versus control; χ2 test. Activity ratio = (DR + 1)/(Control + 1).

or Create an Account

Close Modal
Close Modal